• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Ischemic Brain Injury Ameliorated ByActivation Of Cortical Type 2 Cannabinoid Receptors
A new study published in the March issue of The American Journal of Pathology suggests that cortical type 2 cannabinoid (CB2) receptors might serve as potential therapeutic targets for cerebral ischemia. Researchers found that the cannabinoid trans-caryophyllene (TC) protected brain cells from the effects of ischemia in both in vivo and in vitro animal models. In rats, post-ischemic treatment with TC decreased cerebral infarct size and edema...
Source: Health News from Medical News Today - February 26, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Nationwide Study Maps Atherosclerotic Disease Heredity
Researchers at Lund University in Sweden have mapped the significance of heredity for common forms of atherosclerotic disease. No studies have previously examined whether different forms of the disease share heredity. The study looked at coronary heart disease, ischemic stroke, peripheral arterial disease and atherosclerosis of the aorta in individuals whose siblings and parents have suffered different types of cardiovascular disease...
Source: Health News from Medical News Today - May 23, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news

Motor relearning program improves neurological function of brain ischemia
The motor relearning program can significantly improve various functional disturbance induced by ischemic cerebrovascular diseases. However, its mechanism of action remains poorly understood. According to a study published in Neural Regeneration Research (Vol. 8, No. 16, 2013), models of ischemic brain injury in the rhesus macaque were induced by electrocoagulation of the M1 segment of the right middle cerebral artery, then the motor relearning program was after model establishment...
Source: Health News from Medical News Today - July 26, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

L-3-n-butylphthalide protects against cognitive dysfunction in vascular dementia
3-N-butylphthalide, a green botanical medicine, is a successfully synthesized and stable chemical drug used for the treatment of ischemic stroke that has independent intellectual property rights in China. The first L-isomer, originally extracted from celery seed, was artificially synthesized from racemic acid, also known as butylphthalide. L-3-n-butylphthalide has been shown to reduce β-amylase-induced neuronal apoptosis and improve cognitive function in Alzheimer's disease animal models...
Source: Health News from Medical News Today - August 12, 2013 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Medical News Today: Vegetarian heart health: Study identifies benefits and risks
A new study concludes that a vegetarian diet reduces the risk of ischemic heart disease. It also finds a small but surprising increased risk of stroke.
Source: Health News from Medical News Today - September 7, 2019 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Pages: 1  2  3  4